Clinical trial
Spasmolytic (Otilonium Bromide) Use in Upper Gastrointestinal Endoscopy: Randomized Prospective Trial
NCT02576340 is registered in ClinicalTrials.gov with Konya Meram State Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Spasmolytic (Otilonium Bromide) Use in Upper Gastrointestinal Endoscopy: Randomized Prospective Trial
- Lead sponsor
- Konya Meram State Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2013
- Completion date
- June 30, 2013
- Enrollment
- 400 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
gastroscopy